Meridian Bioscience (VIVO) Tops Q2 EPS by 3c, Beat on Revenues; Reaffirms FY Guidance

Go back to Meridian Bioscience (VIVO) Tops Q2 EPS by 3c, Beat on Revenues; Reaffirms FY Guidance
Meridian Bioscience, Inc. (NASDAQ: VIVO) Delayed: 4.22 +0.17 (4.20%)
Previous Close $4.05    52 Week High $21.49 
Open $4.05    52 Week Low $15.75 
Day High $4.27    P/E 4.80 
Day Low $4.00    EPS $0.88 
Volume 285,966